GIS vs INTS
General Mills Inc (GIS) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported GIS revenue for 2025-05-25 was $4.56B. Net income was $2.32B. Revenue was down 5.9% from 2025-02-23 to 2025-05-25. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
INTS does not have a complete income-statement cache yet.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. INTS currently screens at market cap $7.7M.
Not investment advice. Open the GIS and INTS stock pages for the full models.
Not investment advice.